Health Catalyst, Inc.

HCAT Nasdaq SEC CIK 1636422
Follow Health Catalyst Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $56.3M −26.3% vs same quarter last year
Net income $40.5M +282.2% vs same quarter last year
EPS, diluted $0.53 +265.6% vs same quarter last year
Operating cash flow −$1.9M −304.1% vs same quarter last year
Revenue by quarter
$79.6M
$79.4M
$80.7M
$76.3M
$74.7M
$70.8M
$70.5M
$56.3M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income10 fiscal years
  • Revenue
  • Net income
−$200M$0$200M$400MFY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$311.1M−$178M
FY24$306.6M−$69.5M
FY23$295.9M−$118.1M
FY22$276.2M−$137.4M
FY21$241.9M−$153.2M
FY20$188.8M−$115M
FY19$154.9M−$60.1M
FY18$112.6M−$62M
FY17$73.1M−$47M
FY16--
MarginsShare of revenue
  • Operating margin
  • Net margin
−80%−60%−40%−20%0%FY17FY19FY21FY23FY25
Show the numbers
YearOperating marginNet margin
FY25−51.7%−57.2%
FY24−22.8%−22.7%
FY23−42.9%−39.9%
FY22−50.7%−49.7%
FY21−59.4%−63.3%
FY20−50.9%−60.9%
FY19−35.4%−38.8%
FY18−53.4%−55.1%
FY17−62.3%−64.4%
FY16--
Free cash flowOperating cash flow minus capital expenditure
−$60M−$40M−$20M$0$20MFY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$237K
FY24$12.9M
FY23−$34.3M
FY22−$37.4M
FY21−$33.6M
FY20−$33.9M
FY19−$34.2M
FY18−$42.4M
FY17−$39.3M
FY16-
Returned to shareholdersDividends paid and shares bought back
$0$2.5M$5M$7.5M$10MFY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25$5M
FY24$0
FY23$1.8M
FY22$8.4M
FY21$0
FY20$0
FY19$0
FY18$8.7M
FY17$0
FY16-
Net margin vs the sectorMedian of Technology companies filing with the SEC
  • Health Catalyst
  • Technology median
−80%−60%−40%−20%0%20%FY17FY19FY21FY23FY25
Show the numbers
YearHealth CatalystTechnology median
FY25−57.2%−2.4%
FY24−22.7%−5%
FY23−39.9%−6.7%
FY22−49.7%−4.4%
FY21−63.3%−1.7%
FY20−60.9%−3%
FY19−38.8%0%
FY18−55.1%0.8%
FY17−64.4%2%
FY16-2.3%